Drug Profile
BAY 1214784
Alternative Names: BAY1214784Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Bayer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Undefined(In volunteers) in Germany (PO, Liquid)
- 01 Sep 2014 Phase-I clinical trials in Undefined indication (In volunteers) in Germany (PO)
- 07 Aug 2014 Preclinical trials in Undefined indication in Germany (PO)